Colleen Stugard has been appointed as the new vice president of industry relations at AvevoRx, a national provider of specialty infusion pharmacy services. This strategic move is designed to strengthen partnerships with pharmaceutical manufacturers and improve patient access to complex therapies.
Based in Greensboro, N.C., AvevoRx is committed to expanding its high-touch infusion model and enhancing its clinical capabilities. Stugard, a veteran in the biotech and specialty pharmacy sectors with over 20 years of experience, will lead initiatives aimed at establishing limited distribution drug partnerships and supporting the launch of new therapies.
In her role, Stugard will focus on the following key areas:
- Strengthening relationships with pharmaceutical manufacturers
- Securing limited distribution drug partnerships
- Aligning clinical programs with payer expectations
- Reducing barriers to care for patients with chronic and rare diseases
Phil Rielly, co-founder of AvevoRx, remarked on Stugard’s unique qualifications: “Colleen brings a rare combination of biotech launch expertise, reimbursement strategy, and hands-on specialty pharmacy leadership. Her ability to foster strategic collaboration with manufacturers will be invaluable as we build a high-touch operational platform. “
Stugard’s extensive background includes senior leadership roles where she has led national and regional sales teams across healthcare, biotechnology, and pharmaceutical sectors. Her expertise in developing adaptable reimbursement strategies and her collaborative work with manufacturers will be key components of her strategy at AvevoRx.
As part of her responsibilities, Stugard is set to enhance AvevoRx’s performance transparency, data-driven insights, and shared accountability methods. She will also focus on expanding relationships with manufacturers who require integrated nursing, advocacy, and field reimbursement support, all of which align closely with AvevoRx’s relationship-based care model.
Expressing her enthusiasm for her new role, Stugard stated, “I am thrilled to join AvevoRx at such a pivotal time in the company’s growth. The specialty infusion market requires both disciplined business strategy and deep empathy for the patient journey. My goal is to expand our partnerships in ways that accelerate speed to therapy, improve adherence, and ensure patients experience seamless access to the care they need.”
At AvevoRx, Stugard will drive trade strategy by leveraging her long-standing relationships to uncover and secure limited distribution channel opportunities, particularly for therapies that require intensive support and coordination. Her focus will be on high-touch, complex patient populations and ensuring that distribution models align with both clinical and operational needs.
AvevoRx is dedicated to providing the highest-quality, personalised care tailored to patients with complex, chronic disorders. The company operates through specialized pharmacy locations, field nurses, and dedicated support staff across the United States. In addition to its specialty infusion pharmacy services, AvevoRx also offers acute infusion therapies for patients with short-term therapeutic needs.
Founded in 2021 by industry veterans with over 130 years of combined experience, AvevoRx is privately held and headquartered in North Carolina. To learn more about AvevoRx and its services, please visit www.AvevoRx.com or follow the company on LinkedIn and Instagram.
Media Contact:
Richard Kendall, AvevoRx
Phone: 1 6193462084
Email: richard.kendall@avevorx.com
Website: https://avevorx.com/